GW

GW Vitek CO.,LTD.

Develops research antibodies and distributes scientific instruments for life science researchers.

036180 | KO

Overview

Corporate Details

ISIN(s):
KR7036180008
LEI:
Country:
South Korea
Address:
서울특별시 금천구 벚꽃로 244 1101호(가산동, 벽산디지털밸리5차), 서울특별시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

GW Vitek CO., LTD. is a biotechnology company that provides comprehensive solutions and products for the life sciences research market. The company operates through two primary segments: a Bio division focused on the development, manufacturing, and sale of research antibodies, and a Scientific division that distributes a wide range of scientific instruments and laboratory equipment. Its portfolio includes products for imaging, chromatography, metabolic analysis, and general laboratory use. By collaborating with global partners, GW Vitek aims to deliver innovative and optimal solutions to support the entire research process for scientists and research institutions. The company was formerly known as A-Frontier Co Ltd.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-15 00:00
M&A Activity
기타경영사항(자율공시) (회생회사 지더블유바이텍 주식회사 M&A 공고)
Korean 10.7 KB
2025-09-05 00:00
Legal Proceedings Report
[기재정정]회생절차개시결정
Korean 13.0 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.3 MB
2025-08-14 00:00
Audit Report / Information
반기검토(감사)의견부적정등사실확인(자본잠식률100분의50이상또는자기자본10억원미만포함)
Korean 12.5 KB
2025-08-13 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 1.8 MB
2025-08-06 00:00
Legal Proceedings Report
[기재정정]회생절차개시결정
Korean 12.6 KB
2025-07-04 00:00
Share Issue/Capital Change
[기재정정]감자결정(자회사의 주요경영사항)
Korean 19.2 KB
2025-06-10 00:00
Share Issue/Capital Change
감자결정(자회사의 주요경영사항)
Korean 14.6 KB
2025-06-04 00:00
Legal Proceedings Report
[기재정정]회생절차개시결정
Korean 12.2 KB
2025-05-27 00:00
Regulatory News Service
불성실공시법인지정
Korean 7.7 KB
2025-05-26 00:00
Legal Proceedings Report
[기재정정]회생절차개시결정
Korean 12.2 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.2 MB
2025-04-29 00:00
Regulatory News Service
불성실공시법인지정예고 (공시번복 2건)
Korean 6.3 KB
2025-04-10 00:00
Delisting Announcement
기타시장안내 (상장폐지 관련 이의신청서 접수 및 개선기간 부여)
Korean 3.9 KB
2025-04-10 00:00
Delisting Announcement
주권매매거래정지기간변경 (개선기간 부여)
Korean 5.2 KB

Automate Your Workflow. Get a real-time feed of all GW Vitek CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GW Vitek CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GW Vitek CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Genmab Logo
Creates and develops antibody therapeutics for the treatment of cancer and serious diseases.
Denmark
GMAB
GENOLUTION INC. Logo
Develops molecular diagnostic and RNAi solutions for genetic testing and life sciences research.
South Korea
225220
Genome&Company Logo
Clinical-stage biopharma developing cancer therapies using microbiome, immune inhibitors, and ADCs.
South Korea
314130
Develops molecular diagnostics using DNA methylation biomarkers for early cancer detection.
South Korea
228760
Genomtec S.A. Logo
Develops a mobile platform for rapid, precise genetic diagnostics at the point-of-care.
Poland
GMT
GENOTECH CORP. Logo
A biotech firm offering gene synthesis, genome analysis, and biopharmaceutical products globally.
South Korea
066830
Genprex, Inc. Logo
A clinical-stage firm developing non-viral gene therapies for cancer and diabetes.
United States of America
GNPX
Gentian Diagnostics ASA Logo
Develops & manufactures IVD immunoassays for human & veterinary disease diagnostics.
Norway
GENT
GERON CORP Logo
Commercializes an approved, first-in-class telomerase inhibitor for blood cancers.
United States of America
GERN
GH Research PLC Logo
Clinical-stage biopharma developing mebufotenin therapies for psychiatric disorders.
United States of America
GHRS

Talk to a Data Expert

Have a question? We'll get back to you promptly.